XERS
NASDAQ · Pharmaceuticals
Xeris Biopharma Holdings Inc
$6.53
-0.10 (-1.51%)
Analyst Consensus
Strong Buy
13
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+614.4% upside
Low Target
$35.62
Average Target
$46.65
High Target
$60.75
Current Price
$6.53
Current
$6.53
$6.53
Target
$46.65
$46.65
$35.62
$46.65 avg
$60.75
Scenario Analysis
Bear Case
$35.62
445.5%
Low target
Base Case
$46.65
+614.4%
Avg target
Bull Case
$60.75
+830.3%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$10.08
-35.2% from high
52-Week Low
$4.30
+51.9% from low
Target vs 52W High
$46.65
+362.8% vs high
Peer Consensus — Pharmaceuticals